Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
22,107,985
-
Total 13F shares
-
13,170,929
-
Share change
-
+13,170,929
-
Total reported value
-
$186,240,391
-
Price per share
-
$14.14
-
Number of holders
-
56
-
Value change
-
+$186,240,391
-
Number of buys
-
56
Institutional Holders of Adverum Biotechnologies, Inc. - Common Stock, $0.0001 par value per share (ADVM) as of Q1 2024
As of 31 Mar 2024,
Adverum Biotechnologies, Inc. - Common Stock, $0.0001 par value per share (ADVM) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,170,929 shares.
The largest 10 holders included
VR Adviser, LLC, Vivo Capital, LLC, Logos Global Management LP, VANGUARD GROUP INC, FMR LLC, BML Capital Management, LLC, FRANKLIN RESOURCES INC, COMMODORE CAPITAL LP, MORGAN STANLEY, and 5AM Venture Management, LLC.
This page lists
56
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.